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The last 15 years have seen great improvements in thedevelopment of clinical practice guidelines. There arenow rigorous methods for conducting systematic re-
views of the relevant scientific evidence and for grading the
strength of that evidence.1 However, it is in the next step of
the process (generating and implementing recommendations
for practice) that difficulties frequently arise. The grade of
scientific evidence cannot simply dictate the priorities for
clinical practice because of the crucial role of several other
considerations. Judgements about the implementation of ev-
idence will include judgements about patient needs, the size
and value of treatment effects, and the most appropriate use
of resources within a particular healthcare system (and
society in general). It is for these reasons that clinical practice
guidelines should be developed within the social and cultural
context in which they will be applied. In guideline develop-
ment, this priority setting process has usually reflected the
assembled views of the guideline panel and has not been
carried out in an explicit manner. Once guidelines come to be
implemented in clinical practice, priorities often reflect the
intuitive decision-making of clinicians and healthcare
managers.
The article by Norrving et al2 outlines a novel approach to
priority-setting during the development of the Swedish na-
tional stroke guidelines. They established a series of commit-
tees with a broad representation of many stakeholders includ-
ing patient representatives. The approach is to be commended
because it attempted to make transparent a series of decisions,
which are frequently implicit.
Inevitably a number of questions arise. Despite the empha-
sis on transparency, it is not always clear exactly how some
decisions are arrived on. The reliability of the methods used
need to be tested in other settings. This is particularly
important when rationing decisions may be taken based
largely on economic considerations. Overall, the Swedish
guideline development group have taken an important step in
trying to establish a transparent and reliable approach to
setting priorities. However, I suspect we are nearer the
beginning of this journey than the end.
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